United States · FDA National Drug Code directory

ERLOTINIB HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62332-566_78cde6f1-5cd7-428e-8ae8-e707d4d5f484
Product NDC: 62332-566
Form: TABLET, FILM COATED
Composition / generic term: ERLOTINIB HYDROCHLORIDE
Labeler: Alembic Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20210709
Source listing expiry: 20261231

Source-listed ingredients

ERLOTINIB HYDROCHLORIDE — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, FILM COATED in 1 BOTTLE (62332-566-30) · 62332-566-30
90 TABLET, FILM COATED in 1 BOTTLE (62332-566-90) · 62332-566-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →